Insider Transactions in Q1 2021 at Landos Biopharma, Inc. (LABP)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2021
|
Konstantin Poukalov Director |
BUY
Open market or private purchase
|
Indirect |
99,681
+0.33%
|
$1,395,534
$14.2 P/Share
|
|
Feb 09
2021
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
99,681
+0.68%
|
$1,395,534
$14.2 P/Share
|
|
Feb 08
2021
|
Konstantin Poukalov Director |
BUY
Open market or private purchase
|
Indirect |
1,373,053
+2.18%
|
$17,849,689
$13.25 P/Share
|
|
Feb 08
2021
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,373,053
+4.19%
|
$17,849,689
$13.25 P/Share
|
|
Feb 08
2021
|
Konstantin Poukalov Director |
BUY
Conversion of derivative security
|
Indirect |
13,369,728
+50.0%
|
-
|
|
Feb 08
2021
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
13,369,728
+43.2%
|
-
|
|
Feb 08
2021
|
Rtw Investments, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,650,722
+46.06%
|
-
|
|
Feb 05
2021
|
Konstantin Poukalov Director |
BUY
Open market or private purchase
|
Indirect |
27,453
+0.19%
|
$301,983
$11.14 P/Share
|
|
Feb 05
2021
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
27,453
+0.39%
|
$301,983
$11.14 P/Share
|
|
Feb 04
2021
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
625,000
+50.0%
|
$10,000,000
$16.0 P/Share
|